Page last updated: 2024-10-28

gyki 52466 and Neurodegenerative Diseases

gyki 52466 has been researched along with Neurodegenerative Diseases in 1 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kapus, G1
Székely, JI1
Durand, J1
Ruiz, A1
Tarnawa, I1

Other Studies

1 other study available for gyki 52466 and Neurodegenerative Diseases

ArticleYear
AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the induction of long-term potentiation at therapeutically relevant concentrations.
    Brain research bulletin, 2000, Volume: 52, Issue:6

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Dose-Response Relationship, Drug; Epilepsy; Excitator

2000
chemdatabank.com